首页> 外文期刊>Science of the total environment >In Vitro Analysis Of Inflammatory Responses Following Environmental Exposure To Pharmaceuticals And Inland Waters
【24h】

In Vitro Analysis Of Inflammatory Responses Following Environmental Exposure To Pharmaceuticals And Inland Waters

机译:环境暴露于药物和内陆水域后的炎症反应体外分析

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmaceuticals are regularly released into the environment; in particular non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics. Erythromycin, naproxen, furosemide and atenolol are reported to be stable for up to 1 year in the environment, which increases the risk for accumulation. In the present study we have measured the occurrence and concentration of Pharmaceuticals in river Viskan (Jossabron) downstream of a sewage treatment plant in Boras, Sweden. Pharmaceuticals and water samples were tested for potential human risk by evaluating inflammatory responses (NF-κB and AP-1) using human T24 bladder epithelial cells and Jurkat T-cells. NF-κB activity in T24 cells was significantly reduced by all NSAIDs analysed (diclofenac, ketoprofen, naproxen, ibuprophen and dextropropoxyphene), but also by trimethoprim, using environmentally relevant concentrations. NF-κB and AP-1 activation was further analysed in response to water samples collected from different locations in Sweden. Dose-dependent down-regulation of AP-1 activity in Jurkat cells was observed at all locations. At two locations (Joessabron and Almenaes) down-regulation of NF-κB was observed. In contrast, the NF-κB response was potentiated by exposure to water from both locations following activation of NF-κB by treatment with heat-killed Escherichia coli. To determine the involvement of Pharmaceuticals in the responses, T24 cells were exposed to the pharmaceutical mixture, based on the determined levels at Joessabron. This resulted in reduction of the NF-κB response following exposure to the pharmaceutical mixture alone while no potentiation was observed when cells were co-exposed to heat killed E. co!i and Pharmaceuticals. The obtained results demonstrate that the identified pharmaceuticals affect the inflammatory responses and furthermore indicate the presence of unknown substance(s) with the ability to potentiate inflammatory responses.
机译:药品定期释放到环境中;特别是非甾体类抗炎药(NSAID)和抗生素。据报道,红霉素,萘普生,速尿和阿替洛尔在环境中稳定长达1年,这增加了积累的风险。在本研究中,我们测量了瑞典Boras污水处理厂下游的Viskan河(Jossabron)中药物的发生和浓度。通过使用人类T24膀胱上皮细胞和Jurkat T细胞评估炎症反应(NF-κB和AP-1),对药品和水样进行了潜在的人类风险测试。使用所有与环境有关的浓度,分析的所有NSAID(双氯芬酸,酮洛芬,萘普生,布洛芬和右丙氧芬)均可显着降低T24细胞中的NF-κB活性,甲氧苄啶也可降低。根据从瑞典不同地点收集的水样,进一步分析了NF-κB和AP-1的活化。在所有位置均观察到Jurkat细胞中AP-1活性的剂量依赖性下调。在两个位置(Joessabron和Almenaes)观察到NF-κB的下调。相反,通过用热灭活的大肠杆菌处理激活NF-κB后,从两个位置暴露于水可增强NF-κB应答。为了确定药物对应答的参与,根据Joessabron确定的水平,将T24细胞暴露于药物混合物中。单独暴露于药物混合物后,这导致NF-κB响应降低,而将细胞与热杀死的大肠杆菌和药物共暴露时未观察到增强作用。获得的结果证明所鉴定的药物影响炎症反应,并且还表明存在具有增强炎症反应能力的未知物质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号